Advertisement

Reactions Weekly

, Volume 1744, Issue 1, pp 4–4 | Cite as

Gilenya withdrawal linked with MS rebound effect?

News item
  • 18 Downloads

Reference

  1. Government of Canada. Summary Safety Review - Gilenya (fingolimod) - Health Canada. Internet Document : 28 Feb 2019. Available from: URL: https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&linkID=SSR00219

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations